Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Ptc Therapeutics (PTCT)

Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PTC Therapeutics: Q4 Earnings Snapshot AP - Thu Feb 29, 5:19PM CST

PTC Therapeutics: Q4 Earnings Snapshot

PTCT : 25.16 (-0.51%)
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock? Motley Fool - Sun Feb 11, 12:45AM CST

Bad news for one player does not always equal good news for another.

SRPT : 117.89 (+0.51%)
PTCT : 25.16 (-0.51%)
PTC Therapeutics: Q3 Earnings Snapshot AP - Thu Oct 26, 2023

PTC Therapeutics: Q3 Earnings Snapshot

PTCT : 25.16 (-0.51%)
Why PTC Therapeutics Soared 15% Higher Today Motley Fool - Thu Oct 19, 2023

The company scored a $1 billion upfront payment for expanding a commercial partnership.

PTCT : 25.16 (-0.51%)
RPRX : 27.61 (+0.55%)
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2023 Financial Results PR Newswire - Mon Oct 16, 2023

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its third quarter 2023...

PTCT : 25.16 (-0.51%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT PR Newswire - Fri Sep 29, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors...

PTCT : 25.16 (-0.51%)
PTC Announces Further Strategic Prioritization and Associated Reduction in Workforce PR Newswire - Thu Sep 28, 2023

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today further strategic prioritization and associated workforce reduction. The portfolio...

PTCT : 25.16 (-0.51%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT PR Newswire - Thu Sep 21, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors...

PTCT : 25.16 (-0.51%)
CHMP Delivers Opinion on Translarna™ for Conversion to Full Authorization PR Newswire - Fri Sep 15, 2023

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

PTCT : 25.16 (-0.51%)
PTC Therapeutics' 2023 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community PR Newswire - Thu Sep 7, 2023

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the two recipients of its 2023 STRIVE Awards for Duchenne Muscular Dystrophy. Through the...

PTCT : 25.16 (-0.51%)

Barchart Exclusives

This Outperforming Dividend Aristocrat Could Rally Another 22%, Says Analyst Barchart - Wed Apr 17, 6:30PM CDT
With a track record of 30 years of dividend increases, this industrial stock is also delivering some outsized capital appreciation to shareholders lately. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot